SanBio Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Oct'25

Jul'25

Apr'25

Jan'25

Oct'24

Jul'24

Apr'24

Net Sales

0.00

Other Operating Income

0.00

Total Operating income

0.00

Raw Material Cost

1.94

1.93

1.90

1.94

2.48

2.50

2.44

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

9.40

9.75

7.29

2.95

5.31

5.43

5.25

Selling and Distribution Expenses

210.57

255.21

282.31

339.63

266.56

265.52

277.04

Other Expenses

56.39

61.39

71.58

68.86

63.67

63.19

38.18

Total Expenditure (Excl Depreciation)

785.85

880.77

1,007.35

1,033.15

911.01

905.34

666.58

Operating Profit (PBDIT) excl Other Income

-785.8

-880.8

-1007.3000000000001

-1033.1999999999998

-911

-905.3

-666.5999999999999

Other Income

117.68

158.82

-735.64

13.50

105.07

-366.56

763.06

Operating Profit (PBDIT)

-666.23

-720.02

-1,741.09

-1,017.72

-803.46

-1,269.40

98.92

Interest

9.40

9.75

7.29

2.95

5.31

5.43

5.25

Exceptional Items

0.00

9.30

0.00

Gross Profit (PBDT)

-1.94

-1.93

-1.90

-1.94

-2.48

-2.50

-2.44

Depreciation

1.94

1.93

1.90

1.94

2.48

2.50

2.44

Profit Before Tax

-677.57

-731.70

-1,750.28

-1,013.31

-811.25

-1,277.33

91.22

Tax

39.08

-265.95

-218.79

-282.79

31.99

-113.05

236.07

Provisions and contingencies

0.00

Profit After Tax

-716.64

-465.75

-1,531.49

-730.52

-843.24

-1,164.28

-144.85

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

-716.64

-465.75

-1,531.49

-730.52

-843.24

-1,164.28

-144.85

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

-716.64

-465.75

-1,531.49

-730.52

-843.24

-1,164.28

-144.85

Equity Capital

0.00

Face Value

0.0

Reserves

492.19

1,294.17

1,895.02

1,762.92

616.68

1,572.00

2,399.67

Earnings per share (EPS)

-9.95

-6.47

-21.38

-10.47

-12.29

-16.96

-2.12

Diluted Earnings per share

-9.95

-6.47

-21.38

-10.47

-12.29

-16.96

-2.12

Operating Profit Margin (Excl OI)

0.0%

Gross Profit Margin

0.0%

PAT Margin

0.0%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Oct 2025 is 0.00% vs 0.00% in Oct 2024

Consolidate Net Profit

YoY Growth in quarter ended Oct 2025 is 15.01% vs -782.93% in Oct 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Oct 2025 is 13.71% vs -42.67% in Oct 2024

Interest

YoY Growth in quarter ended Oct 2025 is 77.36% vs -8.62% in Oct 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Oct 2025 has improved from Oct 2024

Compare Quarterly Results Of SanBio Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

0.00

8,731.00

-8,731.00

-100.00%

Other Operating Income

0.00

Total Operating income

0.00

8,731.00

-8,731.00

-100.00%

Raw Material Cost

1.94

5,037.00

-5,035.06

-99.96%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

9.40

1.00

8.40

840.00%

Selling and Distribution Expenses

210.57

2,368.00

-2,157.43

-91.11%

Other Expenses

56.39

169.00

-112.61

-66.63%

Total Expenditure (Excl Depreciation)

785.85

9,096.00

-8,310.15

-91.36%

Operating Profit (PBDIT) excl Other Income

-785.85

-365.00

-420.85

-115.30%

Other Income

117.68

233.00

-115.32

-49.49%

Operating Profit (PBDIT)

-666.23

398.00

-1,064.23

-267.39%

Interest

9.40

1.00

8.40

840.00%

Exceptional Items

0.00

Gross Profit (PBDT)

-1.94

3,694.00

-3,695.94

-100.05%

Depreciation

1.94

530.00

-528.06

-99.63%

Profit Before Tax

-677.57

-132.00

-545.57

-413.31%

Tax

39.08

67.00

-27.92

-41.67%

Provisions and contingencies

0.00

Profit After Tax

-716.64

-200.00

-516.64

-258.32%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

-716.64

-200.00

-516.64

-258.32%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

-716.64

-200.00

-516.64

-258.32%

Equity Capital

0.00

Face Value

0.00

Reserves

492.19

71,630.00

-71,137.81

-99.31%

Earnings per share (EPS)

-9.95

-3.66

-6.29

-171.86%

Diluted Earnings per share

-9.95

-3.66

-6.29

-171.86%

Operating Profit Margin (Excl OI)

0.00%

-4.18%

0.00

4.18%

Gross Profit Margin

0.00%

4.56%

0.00

-4.56%

PAT Margin

0.00%

-2.29%

0.00

2.29%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

No Net Sales in the last few periods

Quarterly - Consolidate Net Profit

Consolidate Net Profit -71.66 Million

in Oct 2025

Figures in Million

QoQ Growth in quarter ended Oct 2025 is -53.84% vs 69.59% in Jul 2025

YoY Growth in quarter ended Oct 2025 is 15.01% vs -782.93% in Oct 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) -78.39 Million

in Oct 2025

Figures in Million

QoQ Growth in quarter ended Oct 2025 is 10.80% vs 12.59% in Jul 2025

YoY Growth in quarter ended Oct 2025 is 13.71% vs -42.67% in Oct 2024

Quarterly - Interest

Interest 0.94 Million

in Oct 2025

Figures in Million

QoQ Growth in quarter ended Oct 2025 is -3.09% vs 32.88% in Jul 2025

YoY Growth in quarter ended Oct 2025 is 77.36% vs -8.62% in Oct 2024

Quarterly - Operating Profit Margin (Excl OI)

No Operating Profit Margin (Excl OI) in the last few periods